[an error occurred while processing this directive] [an error occurred while processing this directive]
Research Opportunity Example
04-18-2009
If you have any scientific research connections ...PLEASE READ THIS ENTIRE POST.
I am writing this on behalf of several children I know who are in critical condition.
Relapsed cancer, at the end of traditional treatment, parents fighting hard for extra days and weeks.
For those of you who do not remember part of last year's crisis let me give you a refresher.
I was zeroing in on the "root of leukemia" ...those nasty leukemic "stem cells".
And talking about the drug they are working on which is an analogue of a substance from the plant FeverFew.
It seems one of the main motivations to develop that drug is that parthenolide
(the FeverFew component that kills those cancerous stem cells) is not very "bioavailable".
To make things simple ...even if you take FeverFew tablets, the "good stuff" will probably not
get into your bloodstream. They tried these tablets already (see trial) and gave up trying to achieve measurable plasma parthenolide levels.
To my knowledge they never tried other methods such as teas and/or emulsification.
Instead, they have made this new "look-alike" drug which will take years to wind its way through
various clinical trials in foreign lands before the FDA might possibly approve its use here in the USA.
In the meantime, there is this "underground network" of desperate parents of children with refractory
leukemia, basically ticking time bombs of untreatable disease ...only months or weeks to live. Some of us are managing with
alternative methods
to maintain fragile remissions for months at a time with alternative methods, but the "stem cell" issue still remains.
Will we have to fight off relapses for the rest of our lives, or is there a way to "root out" this disease for good?
I get constant communication from around the world ...people experimenting with different methods to make things like FeverFew and Curcumin more bioavailable.
Their children do not have time to wait for "side-effect" testing, to receive the "greater benefits" of the new drug
...they want to at least leverage the most out of the plant right now ...see studies I've organized.
I thought the following email (we'll keep the author anonomous) was noteworthy (many thanks):